ArticleTrials2019

Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: Study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF).

Xuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.